Targeting survivin for therapeutic discovery: past, present, and future promises
Author:
Funder
US Department of Defense
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference108 articles.
1. Circumventing tumor resistance to chemotherapy by nanotechnology;Liang;Methods Mol. Biol.,2010
2. IAP proteins: blocking the road to death’s door;Salvesen;Nat. Rev. Mol. Cell Biol.,2002
3. Survivin, versatile modulation of cell division and apoptosis in cancer;Altieri;Oncogene,2003
4. Survivin in apoptosis control and cell cycle regulation in cancer;Altieri;Prog. Cell Cycle Res.,2003
5. Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells;Schmidt;Blood,2003
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. SIRT6 suppresses colon cancer growth by inducing apoptosis and autophagy through transcriptionally down-regulating Survivin;Mitochondrion;2024-09
2. Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment;Frontiers in Cell and Developmental Biology;2024-08-30
3. Peptide-Based Turn-On Fluorescent Probes for Highly Specific Detection of Survivin Protein in the Cancer Cells;Chemical & Biomedical Imaging;2024-05-02
4. Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective;Journal of Medicinal Chemistry;2023-12-13
5. Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy;Journal of Medicinal Chemistry;2023-12-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3